SIRT1 and myeloid sarcoma: Our study found that the SIRT1 polymorphisms rs3758391 and rs7895833 are associated with ON and ON during MS development, in contrast to other experimental animal models showing that SIRT1 is a potential candidate for the treatment of MS.